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With interest we read the article by Honarbakhsh et al. about the successful ablation of a 
right ventricular (RV) tachycardia in a patient with left ventricular hypertrabeculation, also 
known as noncompaction (LVHT) [1]. We have the following comments and concerns.      
Though RV ablation is reported as having been successful, it would be interesting to know 
for how long the patient  was followed-up after the procedure.  This point is of particular 
importance  since  the  patient  is  reported  to  have  undergone  RV  ablation  already  before 
(ablation 1) the present procedure (ablation 2). How long was the interval between ablation 1 
and ablation 2? For how long was ablation 1 successful?                                    
A further point is the description of LVHT as a congenital condition. Though presumably 
correct for most of the cases, LVHT may not only be congenital, but also acquired, which 
means that LVHT either develops after birth (truly acquired) or is masked because of severe 
LV dilatation or thickening (hidden LVHT) [2,3]. When was LVHT actually detected in the 
presented patient? Was LVHT detected already before ablation 1? Were echocardiographies 
carried  out  before  ablation  1?                                                  
A third point concerns the cause of LVHT. Nothing is mentioned if the patient carried any of 
the  known mutations  in  genes  so far  reported  in  association  with  LVHT,  such as  TAZ, 
DTNA, ZASP, lamin A/C, MYH7, MYH7B, ACTC1, TNNT2, TNNI3, MYBPC3, TPM1, 
dystrophin,  DMPK,  ZNF9,  LAMP2,  GAA,  mtDNA  genes,  AMPD1,  GBE1,  RYR1, 
COL7A1, PMP22, MMACHC, beta-globin, and DNAJC19 [Finsterer et al., submitted]. In 
this  respect  the  authors  should  provide  information  if  there  was  any  indication  of  a 
neuromuscular disease or a chromosomal abnormality, conditions frequently associated with 
LVHT  [4].                                               
A fourth point is the familiarity of LVHT. Since LVHT is frequently associated with genetic 
defects, it is also frequently familial [5]. Were other family members investigated for LVHT? 
Was  there  any indication  for  hereditary  disease  in  the  patient’s  family?  Was  the  family 
history positive for palpitations or were arrhythmias ever recorded in any of the first degree 
relatives  of  the  patient?                                                      
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The authors should also mention if there was previous stroke or embolism since the patient 
was 67 y at diagnosis of LVHT and assuming that LVHT was truly congenital it is quite 
likely that during such a long period a clinically manifesting or subclinical cerebrovascular 
embolic event had occurred.  Did the patient ever undergo cerebral MRI to document old 
ischemic lesions in an embolic distribution?                                             
Since cause and pathomechanism of LVHT are unknown, it  is  worthwhile  to  provide as 
much information as possible to clarify the many unsolved issues associated with LVHT. 
Though  treatment  of  any complication  of  LVHT is  symptomatic  at  the  moment,  deeper 
insight may give rise to the development of more causal therapeutic concepts.           
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